跨越聚合物链接的合体二元体的全性蛋白质的结合点
1Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Florida 33101, USA. rkramer@chroma.med.miami.edu
Nature
|October 28, 1998
概括
这项研究引入了用于药物发现的聚合物结合联体二元体. 这些新型化合物比现有的配体强大得多,可以在没有先前结构数据的情况下识别有选择性的代理物.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 传统的药物设计依赖于蛋白质结构的确定或随机选.
- 开发具有多个结合点的蛋白质的强效连接体是一个挑战.
- 现有的方法可能需要大量的结构信息或缺乏特异性.
研究的目的:
- 开发一种新的策略,用于为具有多个结合点的蛋白质制造有力和选择性的配体.
- 为了研究聚合物结合的配体二次体在激活特定蛋白质标中的有效性.
- 展示一种在没有先前蛋白质结构数据的情况下识别最佳连接体结构的方法.
主要方法:
- 合成聚合物连接的配体二聚体,通过连接两个配体与一个变长的聚合物链.
- 测试了循环GMP含有的二次体对循环核酸通道和cGMP依赖的蛋白激酶的功效.
- 经验选择了不同点蛋白质的最佳聚合物长度.
主要成果:
- 与周期性GMP部分结合的聚合物链接配体二极体比单独的周期性GMP高出1000倍.
- 每个标蛋白都表现出对二聚体活性的最佳聚合物长度,尽管保留了结合点.
- 最佳的聚合物长度提供了蛋白质结合点之间的距离的估计.
结论:
- 聚合物连接的带二聚合物策略为药物发现提供了一种强大而有选择的方法.
- 这种方法绕过了对目标蛋白的详细结构信息的需求.
- 调整聚合物长度允许基于结合点间距的有效连接体的经验识别.
更多相关视频
08:34OaAEP1-Mediated Enzymatic Synthesis and Immobilization of Polymerized Protein for Single-Molecule Force Spectroscopy
Published on: February 5, 2020
10:01Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
相关概念视频
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
